Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 2, 2017
- Accepted for publication March 20, 2017
- Published online September 1, 2017.
Copyright & Usage
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Matthias Eiber1,2,
- Wolfgang P. Fendler1,3,
- Steven P. Rowe4,
- Jeremie Calais1,
- Michael S. Hofman5,
- Tobias Maurer6,
- Sarah M. Schwarzenboeck7,
- Clemens Kratowchil8,
- Ken Herrmann9 and
- Frederik L. Giesel8
- 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
- 2Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
- 3Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
- 4Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, Maryland
- 5Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- 6Department of Urology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
- 7Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany
- 8Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany; and
- 9Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany
- For correspondence or reprints contact: Matthias Eiber, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, 200 Medical Plaza, Suite B144, Los Angeles, CA 90095. E-mail: matthias.eiber{at}tum.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Matched-Pair Comparison of 18F-DCFPyL PET/CT and 18F-PSMA-1007 PET/CT in 240 Prostate Cancer Patients: Interreader Agreement and Lesion Detection Rate of Suspected Lesions
- The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
- PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
- Comparison of 3 Interpretation Criteria for 68Ga-PSMA11 PET Based on Inter- and Intrareader Agreement
- Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
- Prostate-Specific Membrane Antigen-Guided Surgery
- Lymph Node Involvement in Treatment-Naive Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management
- 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney
- The Future of Nuclear Medicine as an Independent Specialty
- qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT
- Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
- Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
- Early Experience of Rechallenge 177Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer
- Entering the Era of Molecularly Targeted Precision Surgery in Recurrent Prostate Cancer
- Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer
- One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer
- A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
- A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies
- Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot Study
- Proposed Criteria Positions PSMA PET for the Future
- Theranostic Concepts: More Than Just a Fashion Trend--Introduction and Overview